<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101300215</journal-id>
<journal-id journal-id-type="pubmed-jr-id">33297</journal-id>
<journal-id journal-id-type="nlm-ta">Dev Neurobiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Dev Neurobiol</journal-id>
<journal-title-group>
<journal-title>Developmental neurobiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">1932-8451</issn>
<issn pub-type="epub">1932-846X</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28901728</article-id>
<article-id pub-id-type="pmc">6589839</article-id>
<article-id pub-id-type="doi">10.1002/dneu.22536</article-id>
<article-id pub-id-type="manuscript">NIHMS1032851</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>GABA Type A Receptor Trafficking and the Architecture of Synaptic Inhibition</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Lorenz-Guertin</surname>
<given-names>Joshua M.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-9686-947X</contrib-id>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jacob</surname>
<given-names>Tija C.</given-names>
</name>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8288-7885</contrib-id>
</contrib>
<aff id="A1">Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, 15261</aff>
</contrib-group>
<author-notes>
<corresp id="CR1"><italic>Correspondence to:</italic> T. C. Jacob (<email>tcj11@pitt.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>8</day>
<month>6</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>9</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="ppub">
<month>3</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>24</day>
<month>6</month>
<year>2019</year>
</pub-date>
<volume>78</volume>
<issue>3</issue>
<fpage>238</fpage>
<lpage>270</lpage>
<!--elocation-id from pubmed: 10.1002/dneu.22536-->
<abstract id="ABS1">
<p id="P1">Ubiquitous expression of GABA type A receptors (GABA<sub>A</sub>R) in the central nervous system establishes their central role in coordinating most aspects of neural function and development. Dysregulation of GABAergic neurotransmission manifests in a number of human health disorders and conditions that in certain cases can be alleviated by drugs targeting these receptors. Precise changes in the quantity or activity of GABA<sub>A</sub>Rs localized at the cell surface and at GABAergic postsynaptic sites directly impact the strength of inhibition. The molecular mechanisms constituting receptor trafficking to and from these compartments therefore dictate the efficacy of GABA<sub>A</sub>R function. Here we review the current understanding of how GABA<sub>A</sub>Rs traffic through biogenesis, plasma membrane transport, and degradation. Emphasis is placed on discussing novel GABAergic synaptic proteins, receptor and scaffolding posttranslational modifications, activity-dependent changes in GABA<sub>A</sub>R confinement, and neuropeptide and neurosteroid mediated changes. We further highlight modern techniques currently advancing the knowledge of GABA<sub>A</sub>R trafficking and clinically relevant neurodeve lopmental diseases connected to GABAergic dysfunction.</p>
</abstract>
<kwd-group>
<kwd>GABA<sub>A</sub>R</kwd>
<kwd>trafficking</kwd>
<kwd>synapse</kwd>
<kwd>inhibition</kwd>
<kwd>plasticity</kwd>
</kwd-group>
</article-meta>
</front>
</article>
</pmc-articleset>